Postmortem Blood Concentrations of R- and S-Enantiomers of Methadone and EDDP in Drug Users: Influence of Co-Medication and P-glycoprotein Genotype
Anders Buchard M.Sc.
Section of Forensic Genetics, Department of Forensic Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Search for more papers by this authorKristian Linnet M.D., D.M.Sc.
Section of Forensic Chemistry, Department of Forensic Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Search for more papers by this authorSys Stybe Johansen Ph.D.
Section of Forensic Chemistry, Department of Forensic Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Search for more papers by this authorJulie Munkholm M.D.
Section of Forensic Pathology, Department of Forensic Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Search for more papers by this authorMichael Fregerslev M.D.
Section of Forensic Pathology, Department of Forensic Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Search for more papers by this authorNiels Morling M.D., D.M.Sc.
Section of Forensic Genetics, Department of Forensic Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Search for more papers by this authorAnders Buchard M.Sc.
Section of Forensic Genetics, Department of Forensic Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Search for more papers by this authorKristian Linnet M.D., D.M.Sc.
Section of Forensic Chemistry, Department of Forensic Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Search for more papers by this authorSys Stybe Johansen Ph.D.
Section of Forensic Chemistry, Department of Forensic Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Search for more papers by this authorJulie Munkholm M.D.
Section of Forensic Pathology, Department of Forensic Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Search for more papers by this authorMichael Fregerslev M.D.
Section of Forensic Pathology, Department of Forensic Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Search for more papers by this authorNiels Morling M.D., D.M.Sc.
Section of Forensic Genetics, Department of Forensic Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Search for more papers by this authorAbstract
Abstract: We investigated toxicological and pharmacogenetic factors that could influence methadone toxicity using postmortem samples. R- and S-methadone were measured in femoral blood from 90 postmortem cases, mainly drug users. The R-enantiomer concentrations significantly exceeded that of the S-enantiomers (Wilcoxon’s test, p < 0.001). The samples were divided into four groups according to other drugs detected (methadone only, methadone and strong analgesics, methadone and benzodiazepines, or methadone and other drugs). There was no significant difference in any of the R-methadone/total methadone ratios among the four groups. The median R/S ratio was 1.38, which tends to be higher than that reported for the plasma of living subjects. In addition, we investigated whether small nucleotide polymorphisms in the MDR1 gene that encode the drug transporter P-glycoprotein were associated with the concentrations of R- and S-methadone and its metabolite 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine. No significant association was detected.
References
- 1 Gagajewski A, Apple FS. Methadone-related deaths in Hennepin County, Minnesota: 1992–2002. J Forensic Sci 2003; 48: 668–71.
- 2 Milroy CM, Forrest AR. Methadone deaths: a toxicological analysis. J Clin Pathol 2000; 53: 277–81.
- 3 Wolf BC, Lavezzi WA, Sullivan LM, Flannagan LM. Methadone-related deaths in Palm Beach County. J Forensic Sci 2004; 49: 375–8.
- 4 OH Drummer, M Odell, editors. The forensic pharmacology of drugs of abuse. London: Arnold, 2001.
- 5 Kristensen K, Christensen CB, Christrup LL. The μ1, μ2, δ, κ opioid receptor binding profiles of methadone stereoisomers and morphine. Life Sci 1995; 56: 45–50.
- 6 Foster DJR, Somogyi AA, Dyer KR, White JM, Bochner F. Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients. Br J Clin Pharmacol 2000; 50: 427–40.
- 7 Rodriguez-Rosas ME, Medrano JG, Epstein DH, Moolchan ET, Preston KL, Wainer IW. Determination of total and free concentrations of the enantiomers of methadone and its metabolite in human plasma by enantioselective liquid chromatography with mass spectrometric detection. J Chromatogr A 2005; 1073: 237–48.
- 8 Souverain S, Eap C, Veuthey JL, Rudaz S. Automated LC-MS method for the fast stereoselective determination of methadone in plasma. Clin Chem Lab Med 2003; 41: 1615–21.
- 9 Johansen SS, Linnet K. Chiral analysis of methadone and its main metabolite EDDP in postmortem blood by liquid chromatography-mass spectrometry. J Anal Toxicol 2008; 32: 499–504.
- 10 Linnet K, Johansen SS, Buchard A, Munkholm J, Morling N. Dominance of pre-analytical over analytical variation for measurement of methadone and its main metabolite in postmortem femoral blood. Forensic Sci Int 2008; 179: 78–82.
- 11 Coller JK, Barratt DT, Dahlen K, Loennechen MH, Somogyi AA. ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals. Clin Pharmacol Ther 2006; 80: 682–90.
- 12 Crettol S, Déglon JJ, Besson J, Croquette-Krokar M, Hämmig R, Gothuey I, et al. ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment. Clin Pharmacol Ther 2006; 80: 668–81.
- 13 Crettol S, Déglon JJ, Besson J, Croquette-Krokar M, Hämmig R, Gothuey I, et al. No influence of ABCB1 haplotypes on methadone dosage requirement. Clin Pharmacol Ther 2008; 83: 668–9.
- 14 Levran O, O’Hara K, Peles E, Li D, Barral S, Ray B, et al. ABCB1 (MDR1) Genetic variants are associated with methadone doses required for effective treatment of heroin dependence. Hum Mol Genet 2008; 17: 2219–27.
- 15 Crettol S, Digon P, Golay KP, Brawand M, Eap CB. In vitro P-glycoprotein-mediated transport of (R)-, (S)-, (R,S)-methadone, LAAM and their main metabolites. Pharmacology 2007; 80: 304–11.
- 16 Thörn M, Finnström N, Lundgren S, Rane A, Lööf L. Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract. Br J Clin Pharmacol 2005; 60: 54–60.
- 17 Chinn LW, Kroetz DL. ABCB1 pharmacogenetics: progress, pitfalls, and promise. Clin Pharmacol Ther 2007; 81: 265–9.
- 18 Komar AA. Silent SNPs: impact on gene function and phenotype. Pharmacogenomics 2007; 8: 1075–80.
- 19 Linnet K, Ejsing TB. A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs. Eur Neuropsychopharmacol 2008; 18: 157–69.
- 20 Crettol S, Déglon JJ, Besson J, Croquette-Krokkar M, Gothuey I, Hämmig R, et al. Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment. Clin Pharmacol Ther 2005; 78: 593–604.
- 21 Totah RA, Allen KE, Sheffels P, Whittington D, Kharasch ED. Enantiomeric metabolic interactions and stereoselective human methadone metabolism. J Pharmacol Exp Ther 2007; 321: 389–99.
- 22 Totah RA, Sheffels P, Roberts T, Whittington D, Thummel K, Kharasch ED. Role of CYP2B6 in stereoselective human methadone metabolism. Anesthesiology 2008; 108: 363–74.
- 23 Eap CB, Crettol S, Rougier JS, Schläpfer J, Sintra Grilo L, Déglon JJ, et al. Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers. Clin Pharmacol Ther 2007; 81: 719–28.
- 24 Gwee PC, Tang K, Chua JM, Lee EJ, Chong SS, Lee CG. Simultaneous genotyping of seven single-nucleotide polymorphisms in the MDR1 gene by single-tube multiplex minisequencing. Clin Chem 2003; 49: 672–6.
- 25 Von Wurmb-Schwark N, Preusse-Prange A, Heinrich A, Simeoni E, Bosch T, Schwark T. A new multiplex-PCR comprising autosomal and y-specific STRs and mitochondrial DNA to analyze highly degraded material. Forensic Sci Int Genet 2009; 3: 96–103.
- 26 Eap CB, Finkbeiner T, Gastpar M, Scherbaum N, Powell K, Baumann P. Replacement of (R)-methadone by a double dose of (R, S)-methadone in addicts: interindividual variability of the (R)/(S) ratios and evidence of adaptive changes in methadone pharmacokinetics. Eur J Clin Pharmacol 1996; 50: 385–9.
- 27 Mitchell TB, Dyer KR, Newcombe D, Salter A, Somogyi AA, Bochner F, et al. Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposure. Br J Clin Pharmacol 2004; 58: 609–17.
- 28 Baselt RC. Disposition of toxic drugs and chemicals in man, 7th edn. Foster City, CA: Biomedical Publications, 2004;679.
- 29 Prouty RW, Anderson WH. The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J Forensic Sci 1990; 35: 243–70.
- 30 Levine B, Wu SC, Dixon A, Smialek JE. Site dependence of postmortem blood methadone concentrations. Am J Forensic Med Pathol 1995; 16: 97–100.
- 31 Hoffmeyer S, Burk O, Von Richter O, Arnold HP, Brockmöller J, Johne A, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 2000; 97: 3473–8.
- 32 Kroetz DL, Pauli-Magnus C, Hodges LM, Huang CC, Kawamoto M, Johns SJ, et al. Pharmacogenetics of Membrane Transporters Investigators. Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. Pharmacogenetics 2003; 13: 481–94.
- 33 Tan EK, Drozdzik M, Bialecka M, Honczarenko K, Klodowska-Duda G, Teo YY, et al. Analysis of MDR1 haplotypes in Parkinson’s disease in a white population. Neurosci Let 2004; 372: 240–4.
- 34 Corkery JM, Schifano F, Ghodse AH, Oyefeso A. The effects of methadone and its role in fatalities. Hum Psychopharmacol Clin Exp 2004; 19: 565–76.
- 35 Drummer OH, Opeskin K, Syrjanen M, Cordner SM. Methadone toxicity causing death in ten subjects starting on a methadone maintenance program. Am J Forensic Med Pathol 1992; 13: 346–50.
Citing Literature
